Philadelphia, PA · Founded 2021 · Privately Held (backing)
Operator of a T-cell therapeutics company intended to offer a therapeutic pipeline targeting clinical needs in oncology and autoimmune disease. ViTToria Biotherapeutics is based in Philadelphia, PA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2024, the last priced event on record. It has raised $49.9 million across 1 recorded round; the latest was an $8.7 million early-stage round in Jul 2021.
PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2024
Total raised
$49.9M
Last round
Early Stage VC
Jul 2021
Team — not yet on record
No current team members for ViTToria Biotherapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ViTToria Biotherapeutics with a free account
·The complete investor list: 15 names
·Watch ViTToria Biotherapeutics: the Monday email on marks, rounds and moves
